(Q35171158)

6 August 2017

1 reference

title

Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management (English)

1 reference

6 August 2017

1 reference

1 reference

Joel B Epstein

1

1 reference

6 August 2017

Laura S Wan

series ordinal

2

1 reference

6 August 2017

Meir Gorsky

series ordinal

3

1 reference

6 August 2017

Lewei Zhang

series ordinal

4

1 reference

6 August 2017

publication date

1 July 2003

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

6 August 2017

published in

1 reference

6 August 2017

volume

96

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

32-37

1 reference

The therapy of oral lichen planus

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Oral lichen planus: patient profile, disease progression and treatment responses

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Oral lichen planus: epidemiology, clinical characteristics, and associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Changing oral care needs in the United States: the continuing need for oral medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Clinical characteristics and treatment of patients with oral lichen planus in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Interobserver and intraobserver variability in the histologic assessment of oral lichen planus.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Lichenoid dysplasia: a distinct histopathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Oral lichen planus: a benign lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Epithelial dysplasia in oral lichen planus. A preliminary report of a Dutch-Hungarian study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Oral lichen planus: a potentially premalignant lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

A prospective study of findings and management in 214 patients with oral lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Oral cancer development in patients with oral lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

A review of the recent literature regarding malignant transformation of oral lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

A retrospective study of oral lichen planus patients with concurrent or subsequent development of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Local tumor recurrence or emergence of a new primary lesion? A molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

The potential of molecular screening.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Laser management of oral leukoplakias: a follow-up study of 70 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

DNA content as a prognostic marker in patients with oral leukoplakia.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

High frequency of allelic loss in dysplastic lichenoid lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Use of meta-analysis to evaluate tolonium chloride in oral cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

The role of toluidine blue in assessing margin status after resection of squamous cell carcinomas of the upper aerodigestive tract.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

The role of vital tissue staining in the marginal control of oral squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Oral lichen planus: topical and systemic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Corticosteroid-resistant erosive oral lichen planus successfully treated with topical cyclosporine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Retinoids--which dermatological indications will benefit in the near future?

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Topical application of vitamin A to oral leukoplakia: A clinical case series

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Topical bleomycin for the treatment of dysplastic oral leukoplakia.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Assessing the patient at risk for oral squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Nd:YAG and CO2 laser therapy of oral mucosal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Initial experience in the treatment of oral leukoplakia with high-dose vitamin A and follow-up 5-aminolevulinic acid induced protoporphyrin IX fluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Carbon dioxide laser evaporation of leukoplakia of the lower lip: a retrospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Green tea regulates cell cycle progression in oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

Cancer chemoprevention: progress and promise

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

The effect of retinoids on premalignant oral lesions: focus on topical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2803%2900161-6

7 January 2021

10.1016/S1079-2104(03)00161-6

Identifiers

DOI

1 reference

6 August 2017

1 reference